Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

TLRY Q2 Deep Dive: Regulatory Delays, Margin Focus, and International Momentum Shape Results

TLRY Cover Image

Cannabis company Tilray Brands (NASDAQ: TLRY) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 2.3% year on year to $224.5 million. Its GAAP loss of $1.30 per share was significantly below analysts’ consensus estimates.

Is now the time to buy TLRY? Find out in our full research report (it’s free).

Tilray (TLRY) Q2 CY2025 Highlights:

  • Revenue: $224.5 million vs analyst estimates of $229.2 million (2.3% year-on-year decline, 2% miss)
  • EPS (GAAP): -$1.30 vs analyst estimates of -$0.03 (significant miss)
  • Adjusted EBITDA: $27.64 million vs analyst estimates of $23.69 million (12.3% margin, 16.7% beat)
  • EBITDA guidance for the upcoming financial year 2026 is $67 million at the midpoint, below analyst estimates of $71.84 million
  • Operating Margin: -643%, down from -7.2% in the same quarter last year
  • Market Capitalization: $1.04 billion

StockStory’s Take

Tilray’s second quarter was met with a significant negative market reaction, as the company missed Wall Street’s revenue and earnings expectations. Management attributed the underperformance primarily to delayed export permits in Europe, ongoing consumer softness in its beverage division, and strategic SKU rationalization efforts across its portfolio. CEO Irwin Simon noted that “approximately $8 million” in international cannabis sales were delayed due to regulatory challenges in Portugal and Spain, and the beverage segment saw lower volumes as it completed integration of recent acquisitions. Strategic choices to prioritize higher-margin products and cost efficiencies also led to lower near-term sales, reflecting a cautious tone from leadership regarding current market conditions.

Looking ahead, management’s guidance reflects cautious optimism, with a focus on international cannabis growth, margin expansion through cost control, and continued innovation in beverages and wellness. CFO Carl Merton highlighted that cost savings from Project 420 and a larger contribution from higher-margin segments are expected to gradually improve profitability. However, management acknowledged ongoing headwinds, including regulatory uncertainty in major markets and continued weakness in consumer demand for craft beverages. Simon emphasized, “as we take costs out, as we get efficiencies, as we consolidate facilities...we feel good about scalability,” but cautioned that execution on these initiatives remains critical.

Key Insights from Management’s Remarks

Management cited regulatory delays in Europe, margin-driven SKU reductions, and beverage integration challenges as the main factors shaping quarterly performance and outlook.

  • European regulatory bottlenecks: Delays in export permits from Portugal and Spain prevented over $8 million in international cannabis sales from being recognized in the quarter, with management now seeing resolution and expecting this revenue in the upcoming periods.
  • SKU rationalization impacts: Strategic reduction of lower-margin SKUs in both cannabis and beverage divisions temporarily weighed on sales, as the company exited categories such as vape and infused pre-rolls in Canada and eliminated slower-moving beverage products.
  • Beverage segment transition: The beer business, affected by integration of recent acquisitions and a broader decline in craft beer demand, saw revenue softness. Leadership changes and cost initiatives under Project 420 are being implemented to restore growth and profitability.
  • International cannabis momentum: Despite near-term disruptions, international cannabis revenue grew strongly, particularly in Germany, driven by expanded cultivation and improved distribution infrastructure. Management expects Europe to remain a primary growth engine.
  • Wellness and innovation pipeline: The wellness division reported margin improvements and new product success, including the relaunch of HiBall Energy and hemp-based foods. Continued category innovation is seen as central to future expansion.

Drivers of Future Performance

Tilray’s near-term outlook is driven by international cannabis growth opportunities, cost reduction initiatives, and ongoing innovation, but management remains cautious on regulatory risk and beverage market trends.

  • International expansion and regulatory shifts: Management expects continued growth from medical cannabis in Europe, particularly Germany, and is closely monitoring evolving regulations that could enable new product categories and accelerate market access. However, uncertainty around proposed legislative changes remains a key risk.
  • Margin enhancement and cost discipline: Project 420 is expected to deliver further cost savings and operational efficiencies, with additional benefits from facility consolidation and supply chain optimization. Management believes these measures will offset recent revenue headwinds and drive adjusted EBITDA improvement.
  • Beverage and wellness innovation: New product launches in non-alcoholic beverages, energy drinks, and functional foods are intended to diversify revenues and capture consumer trends. The success of these initiatives is critical to offsetting softness in traditional craft beer sales.

Catalysts in Upcoming Quarters

In upcoming quarters, the StockStory team will watch for (1) resolution of European export permit challenges and recovery in international cannabis sales, (2) measurable progress on Project 420 cost savings and facility integration, and (3) successful rollout and traction of new beverage and wellness innovations. We will also monitor regulatory developments in Germany and the U.S. cannabis landscape, both of which could significantly impact Tilray’s addressable market and strategic direction.

Tilray currently trades at $0.93, up from $0.70 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).

Now Could Be The Perfect Time To Invest In These Stocks

When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.

Don’t let fear keep you from great opportunities and take a look at Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.